1. Anti-programmed cell death-1 (PD-1) monoclonal antibodies involve reversible cranial dura matter. Issue 9 (13th September 2021) Authors: Kataoka, Hiroshi; Shimada, Daisuke; Nanaura, Hitoki; Sugie, Kazuma Journal: Oxford medical case reports Issue: Volume 2021:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR GLIOBLASTOMA. (16th December 2019) Authors: Iijima, Shohei; Saito, Kuniaki; Shimizu, Saki; Kobayashi, Keiichi; Shimada, Daisuke; Matsumoto, Yoshie; Shiokawa, Yoshiaki; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ChemInform Abstract: Nickel‐Catalyzed Ring‐Opening Alkylative Coupling of Enone with Methylenecyclopropane in the Presence of Triethylborane. Issue 29 (1st July 2013) Authors: Ogata, Kenichi; Shimada, Daisuke; Furuya, Shouichi; Fukuzawa, Shin‐ichi Journal: ChemInform Issue: Volume 44:Issue 29(2013) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ChemInform Abstract: Nickel‐Catalyzed Ring‐Opening Alkylative Coupling of Enone with Methylenecyclopropane in the Presence of Triethylborane. Issue 29 (1st July 2013) Authors: Ogata, Kenichi; Shimada, Daisuke; Furuya, Shouichi; Fukuzawa, Shin‐ichi Journal: ChemInform Issue: Volume 44:Issue 29(2013) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. COT-13 THE USEFULNESS OF THE CEREBRAL ANGIOGRAPHY FOR RESECTION OF THE MALIGNANT GLIOMA. (16th December 2019) Authors: Matsumoto, Yoshie; Saito, Kuniaki; Shimada, Daisuke; Amano, Tatsuo; Sasamori, Hiroki; Horikawa, Hiroshi; Kobayashi, Keiichi; Noguchi, Akio; Shiokawa, Yoshiaki; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COT-19 TREATMENT EXPERIENCE OF AND TIPS FOR ADMINISTRATING NOVO TTF. (16th December 2019) Authors: Shimada, Daisuke; Kobayashi, Keiichi; Saito, Kuniaki; Matsumoto, Yoshie; Shiokawa, Yoshiaki; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. COT-20 PERIOPERATIVE STATUS OF SERUM D-DIMER LEVEL AND VENOUS THROMBOSIS IN PATIENTS WITH MALIGNANT BRAIN TUMOR. (16th December 2019) Authors: Shimada, Daisuke; Kobayashi, Keiichi; Saito, Kuniaki; Matsumoto, Yoshie; Iijima, Shohei; Shiokawa, Yoshiaki; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-65. COMBINED RITUXIMAB, METHOTREXATE, PROCARBAZINE, VINCRISTINE, AND CYTARABINE (R-MPV-A) TREATMENT FOR PATIENTS WITH RELAPSED PRIMARY CNS LYMPHOMA. (9th November 2020) Authors: Nagane, Motoo; Sasaki, Nobuyoshi; Kobayashi, Keiichi; Saito, Kuniaki; Shimada, Daisuke; Matsumoto, Yoshie; Iijima, Shohei; Yamagishi, Yuki; Shimizu, Saki; Takayama, Nobuyuki; Shiokawa, Yoshiaki Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma. (28th November 2020) Authors: Nagane, Motoo; Sasaki, Nobuyoshi; Kobayashi, Keiichi; Saito, Kuniaki; Shimada, Daisuke; Matsumoto, Yoshie; Iijima, Shohei; Yamagishi, Yuki; Shimizu, Saki; Sasaki, Yuta; Shiokawa, Yoshiaki Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA. (16th December 2019) Authors: Nagane, Motoo; Kobayashi, Keiichi; Saito, Kuniaki; Shimada, Daisuke; Matsumoto, Yoshie; Iijima, Shohei; Sasaki, Nobuyoshi; Yamagishi, Yuki; Takayama, Nobuyuki; Shiokawa, Yoshiaki Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗